Skip to Content

OP 150 (Lynparza 150 mg)

Generic Name: olaparib

Pill with imprint OP 150 is Green, Elliptical / Oval and has been identified as Lynparza 150 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Lynparza is used in the treatment of ovarian cancer; pancreatic cancer; breast cancer, metastatic; prostate cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OP 150

Lynparza 150 mg OP 150

Lynparza

Generic Name
olaparib
Imprint
OP 150
Strength
150 mg
Color
Green
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
PARP inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC)
00310-0679
Inactive Ingredients
hypromelloses, titanium dioxide, copovidone, silicon dioxide, sodium stearyl fumarate, ferric oxide yellow, water, polyethylene glycol 400, mannitol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "OP 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.